why choose us

First received: November 03, 2022

Clinical Trial: Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Sleep Apnea

Study Type: INTERVENTIONAL


Official Title: Adipose Dysfunction, Imaging, Physiology, and Outcomes With SGLT2i's for Sleep Apnea: The ADIPOSA Study

Brief Summary: The goal of this clinical trial is to test if ertugliflozin lowers the sleep apnea severity in adults who are overweight or obese with moderate to severe obstructive sleep apnea (OSA) compared with a placebo (look-alike substance that contains no active drug).The main question it aims to answer is:If SGLT2i will reduce anatomic and physiologic traits, clinical measures of OSA and sleep deficiency in participantsIf improvement in clinical measures are because of improvement in the anatomic and physiologic…

Read more